Bushi Wang
Impact in
- Internal Medicine top 0.5%
- Venous Thromboembolism Diagnosis and Management
-
- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Antiplatelet Therapy and Cardiovascular Diseases
Papers in
-
- Lung Cancer Treatments and Mutations 9
- Oncology 7
- HER2/EGFR in Cancer Research 4
- Colorectal Cancer Treatments and Studies 3
- Co-authors
- Thorsten Steiner (4 shared papers)Jerrold H. Levy (4 shared papers)Jeffrey I. Weitz (4 shared papers)Stephan Glund (4 shared papers)Pieter W. Kamphuisen (4 shared papers)Frank W. Sellke (4 shared papers)CW Kam (4 shared papers)John W. Eikelboom (4 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Biometrical Journal (3 papers)Statistics in Medicine (2 papers)Research and Practice in Thrombosis and Haemostasis (2 papers)Journal of Biopharmaceutical Statistics (1 paper)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Bushi Wang
24 papers receiving 1.9k citations
Bushi Wang's Hit Papers
Peers
Comparison fields: 5 of 78
- Internal Medicine 504
- Cardiology and Cardiovascular Medicine 795
- Pulmonary and Respiratory Medicine 615
- Oncology 411
- Hematology 104
Countries citing papers authored by Bushi Wang
This map shows the geographic impact of Bushi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bushi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bushi Wang more than expected).
Fields of papers citing papers by Bushi Wang
This network shows the impact of papers produced by Bushi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bushi Wang. The network helps show where Bushi Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Bushi Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Idarucizumab for Dabigatran Reversal Hit paper breakdown → | 2015 | 986 |
| 2 | Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial Hit paper breakdown → | 2015 | 325 |
| 3 | Dual Inhibition of EGFR with Afatinib and Cetuximab in Kinase Inhibitor–Resistant EGFR -Mutant Lung Cancer with and without T790M Mutations Hit paper breakdown → | 2014 | 297 |
| 4 | 2015 | 109 | |
| 5 | 2014 | 28 | |
| 6 | 2017 | 25 | |
| 7 | 2012 | 16 | |
| 8 | 2017 | 15 | |
| 9 | 2018 | 13 | |
| 10 | 2015 | 10 | |
| 11 | 2012 | 9 | |
| 12 | 2017 | 9 | |
| 13 | 2018 | 9 | |
| 14 | 2021 | 8 | |
| 15 | 2015 | 5 | |
| 16 | 2010 | 5 | |
| 17 | 2017 | 5 | |
| 18 | 2016 | 5 | |
| 19 | 2012 | 2 | |
| 20 | 2014 | 2 |
About Bushi Wang
Bushi Wang is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Statistics and Probability, Management Science and Operations Research and Cardiology and Cardiovascular Medicine, having authored 24 papers that have together received 1.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (9 papers), Statistical Methods in Clinical Trials (7 papers), Optimal Experimental Design Methods (6 papers), HER2/EGFR in Cancer Research (4 papers), Venous Thromboembolism Diagnosis and Management (3 papers), Atrial Fibrillation Management and Outcomes (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Advanced Causal Inference Techniques (2 papers). The work is most often cited by research in Internal Medicine (504 citations), Cardiology and Cardiovascular Medicine (795 citations), Pulmonary and Respiratory Medicine (615 citations), Oncology (411 citations) and Hematology (104 citations). Bushi Wang has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Thorsten Steiner, Jerrold H. Levy, Jeffrey I. Weitz, Stephan Glund, Pieter W. Kamphuisen, Frank W. Sellke, CW Kam, John W. Eikelboom, Joachim Stangier and Menno V. Huisman. Their work appears in journals such as Journal of Clinical Oncology, Biometrical Journal, Statistics in Medicine, Research and Practice in Thrombosis and Haemostasis and Journal of Biopharmaceutical Statistics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.